Eumentis Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Eumentis Therapeutics?

Eumentis Therapeutics has 6 investors including U.S. Department of War And Social Starts.

Q: How much funding has Eumentis Therapeutics raised to date?

Eumentis Therapeutics has raised obfuscated.

Overview

Eumentis Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Eumentis Therapeutics

CB Rank

105880

Eumentis is a biopharmaceutical company developing treatments for neuropsychiatric conditions.

Founded

obfuscation

Private

Grant

Boston, Massachusetts, United States

11-50

eumentistx.com/

Biotechnology

Health Care

Medical

Funding Rounds

Grant

OBF

obfuscation

Series A

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Mark Tepper: President & CEO
Past Role: Mass Medical Angels, Member
Randall Marshall: Chief Medical Officer

Details

Legal Name

EuMentis Therapeutics Inc.

Operating Status

Active

Company Type

For Profit

Founders

Stuart Lipton

About the Company

Eumentis is a biopharmaceutical company developing treatments for neuropsychiatric conditions. Its product candidate EM-221 is an oral PDE10A inhibitor designed to modulate the dopamine D2 pathway specifically in the striatum.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

EM-221

A PDE10A inhibitor designed to treat schizophrenia by targeting brain enzyme pathways to address both positive and negative symptoms.

Research & Development

Eumentis Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant
obfuscated obfuscation	Grant - Eumentis Therapeutics	1	obfuscated obfuscation	U.S. Department of War	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Department of War	Yes	Grant - Eumentis Therapeutics	—
U.S. Department of War	Yes	Grant - Eumentis Therapeutics	—
U.S. Department of War	Yes	Grant - Eumentis Therapeutics	—
U.S. Department of War	Yes	Grant - Eumentis Therapeutics	—
U.S. Department of War	Yes	Grant - Eumentis Therapeutics	—